Biosensors Market Size & Share Analysis - Trends, Drivers, Competitive Landscape, and Forecasts (2025 - 2032)

Biosensors Market Dynamics

Increasing Demand from Various Industries Propels Market

• The applications of biosensors are increasing in various industries, such as food, medical, environment, drug discovery, and security.
• Biosensors are used for the detection and identification of diseases in crops and measuring the level of pesticides, herbicides, and heavy metals in soil and groundwater.
• As per the United Nations, over 40% of the water supplied to homes is not treated properly in LMICs, while the WHO estimates the number of people around the world consuming water contaminated with feces at 1.7 billion.
• In the recent years, there have been several initiatives and legislative actions for environmental pollution control.
• In addition, the increasing social and scientific concern about water quality control is increasing the demand for biosensors. The increasing number of harmful pollutants in the environment has created a need for analytical and monitoring devices.
• Similarly, the increasing presence of toxins, chemicals, and pathogens in food is a major concern. Biosensors are used to ensure quality and safety of products and detection of microbial pathogens and toxins in food, and are cost-efficient.
• The World Health Organization says, that 600 million cases of food-borne illnesses and 440,000 resulting deaths are recorded around the world, and they kill 420,000 people each year.
• Biosensors are also used in bio-defense for detection of harmful chemical and biological warfare agents and remote sensing of airborne bacteria.
• Additionally, it is also used for in lie detection tests and forensic identification as part of criminal investigations.
• One key application in this regard is breathalyzers, which are widely used to test for drunken driving.
• As per a survey conducted in Delhi in 2023, over 80% of the respondents admitted driving while drunk at least once.

Rising Demand for Point-of-Care Diagnoses Offers Market Opportunities

• Biosensors are next generation analytical tools for point-of-care testing.
• The demand for point of care testing is increasing, due to increasing requirement of portable and integrated devices.
• It helps perform tests close to the patient and also provide immediate results outside the laboratory.
• It is an important tool used in intensive care units, clinics, emergency rooms and operating theaters.
• It also helps to improve patient care through remote patient care monitoring.
• Further, it helps clinicians to diagnose the cause of disease for immediate management.
• Thus, the increasing demand for point of care testing would reduce the healthcare cost, and help to obtain precise and quick results of analytical tests.
• In addition, POCT testing has the potential to reduce the cost of laboratory testing by providing faster results.
• POCT with the help of biosensors also increases the patient satisfaction and reduces medication risk.
• POCT tool use micro fluidic to bridge the gap between the sampling and analysis.
• In this regard, the growing popularity of wearable medical devices is also significant.
• Home-use vital signs monitors, self-monitoring blood glucose devices, compact polysomnography machines, smartwatches integrated cardiac pulse, blood pressure, respiration rate, and body temperature monitoring features; automated wearable injectors, and other kinds of portable medical devices are increasingly becoming common.
• They not only monitor patients in the comfort of their home but also transmit the biophysical data in the real time to their doctors, allowing for immediate interventions in case of adverse events.

Biosensors Market Segmentation Analysis

Insights by Type

Embedded devices accounted for the larger biosensors market share in 2024, of 70%, and they will also witness the faster growth. This was on account of their burgeoning use in home-based diagnostics, research laboratories, and POC testing. In this regard, the high adoption of IoT in home healthcare settings for real-time tracking, monitoring, and alerting is snowballing the category’s growth. Additionally, in the recent past, there has been an increase in the adoption of embedded solutions integrated with IoT in healthcare settings to tackle the inaccessibility of healthcare professionals in remote areas. These solutions assist in the identification of various disorders and administer different diagnostic tests, to allow doctors to deliver reliable and precise treatments in remote areas.

Furthermore, government organizations have launched various programs to strengthen the field of genomics and proteomics, which is burgeoning the category growth. The demand for embedded biosensors is also expected to grow tremendously owing to the heavy investments done by prominent IT companies, such as Infosys, IBM, and TCS.

These types are analyzed:

• Sensor Patch
• Embedded Device (Larger and Faster-Growing Category)

Insights by Product

Non-wearable sensors dominate the market, simply because of their wider application area. Apart from healthcare, they are used for food quality testing, air and water pollution analysis, farm soil analysis, forensics, and many other applications. Moreover, even in healthcare applications, most sensors are embedded into specialized devices and, therefore, non-wearable.

The demand for wearable biosensors is expected to register the higher CAGR, of 8%, in the forecast period, primarily attributed to their ability to bring the concept of medical diagnostics to the homes of patients, thus saving both medical costs and time. These sensors, incorporated with a physiochemical detector, which analyzes a biological element, aid in the detection of various chemical substances responsible for disease progression. Moreover, wearable analytical devices assist in the early detection of adverse health events and the prevention of hospitalization.

During the COVID-19 pandemic, the prominent players focused on the development of various wearable sensors. For instance, Royal Philips developed the FDA-approved Philips Biosensors BX100, which was widely used at hospitals for the management of patients suffering from the virus. Its real-time data accessibility enables improved clinical conclusions, which leads to enhanced health outcomes and the effectual usage of healthcare systems.

These products are covered:

• Wearable (Faster-Growing Category)
• Non-Wearable (Larger Category)

Insights by Technology

The electrochemical category garnered the largest market share in 2024, of 35%, driven by the surge in the use of this technology for biological and biochemical analyses. The technology offers high stability, a wide linear response range, and no detection limits, thereby resulting in high penetration in the healthcare domain. Furthermore, end users prefer this technology owing to its robust nature, ease of use, cost-effectiveness, high compatibility with novel microfabrication equipment, and lower power consumption.

The optical category is predicted to register the highest CAGR during the forecast period, driven by the ability to be used for a wide range of analytical purposes optical sensors can be used for. Further, they aid in the monitoring of the fermentation process and cell–receptor interactions and in structural research.

These technologies are covered:

• Electrochemical (Largest Category)
• Optical (Fastest-Growing Category)
• Thermal
• Piezoelectric
• Nanomechanical

Insights by Application

Medical testing accounted for the largest market share in 2024. Biosensors are used for assessing, diagnosing, and monitoring various diseases. These devices are easy to use and cost-effective, and they also reduce errors during the diagnosis, which is driving their usage in this application. Additionally, they help track the progression of the disease and monitor treatment outcomes. Cholesterol, cerebrospinal, and pathogen detection are some of the biomarkers these sensors are used to detect.

Glucose detectors are widely available as a minimally invasive and small device, to measure the glucose level in the subcutaneous tissue. The glucose biosensor, an electrochemical sensing device, consists of a screen-printed amperometric disposable electrode. In addition, electrochemical sensors are used to estimate blood cholesterol levels.

Agricultural testing is expected to register the highest CAGR, of 9%, in the forecast period. In contrast to traditional methods of preventing crop and livestock losses due to bioterrorism and natural threats, these devices enable specific detection of a wide range of fungi. These instruments also measure the concentration of heavy metals, pesticides, herbicides, and pesticides in soil water, and ground. They are also used to detect soil diseases and, thus, deliver reliable, enhanced approaches for soil disease prevention at an initial phase.

These applications were studied:

• Medical Testing (Largest Category)
• Industrial Process
• Food Toxicity
• Environment
• Agricultural Testing (Fastest-Growing Category)
• Others

Insights by End User

Research laboratories held the largest share in 2024, of 35%. This is because research laboratories across a variety of industries, including healthcare, agriculture, environmental sciences, forensics, and food & beverage processing utilize an array of biosensors.

Point-of-care testing will witness the fastest growth during the forecast period, owing to the development of ultrasensitive instruments for the POC detection of biomarkers in bodily fluids, such as urine, blood, perspiration, and saliva. These systems provide users with quick and accurate results, allowing for earlier diagnoses and treatment.

These end uses were considered:

• Point-of-Care Testing (Fastest-Growing Category)
• Home Diagnostics
• Research Laboratories (Largest Category)
• Security and Bio-Defense
• Food Industry
• Others

Biosensors Market Regional Outlook

North America led the market in 2024 with a market share of 40%, driven by a growing aging population, increasing health awareness, technological developments in various home-use medical devices, and appropriate insurance coverage. The increasing prevalence of chronic and lifestyle-associated diseases is also driving the growth of the sector. North America uses this technology more than other regions due to the advancements technology and a wider application area across industries. Further, on account of the high healthcare expenditure, these systems are extensively used to accurately, reliably, and quickly detect and prevention of diseases early.

The APAC market is expected to witness the highest CAGR during the forecast period, of 10%. The biosensors market in Asia-Pacific region is growing, due to increasing awareness of clinical outcomes, large population base, growing geriatric population, increase in diabetic population and technological advancement in medical devices & equipment.

The awareness of various diseases and requirement of high-quality care is increasing day by day. In addition, Asia-Pacific has become one of the attractive markets for medical device companies, due to low regulatory requirements and low-cost manufacturing of devices.

The region is also the biggest producer of food and beverages with an increasing focus on quality products. Similarly, the alarming water, soil, and air pollution in China, India, Pakistan, and other regional countries continues to drive environmental analysis activities from governments and private companies. In terms of DALYs, air pollution accounts for over 11% of the overall healthcare burden in India, thus driving the demand for continuous air quality monitoring.

These regions and countries have been analyzed:

• North America
  • U.S. (Larger and Faster-Growing Country Market)
  • Canada
• Europe (Largest Regional Market)
  • Germany (Largest Country Market)
  • France
  • U.K.
  • Italy
  • Spain (Fastest-Growing Country Market)
  • Rest of Europe
• Asia-Pacific (APAC) (Fastest-Growing Regional Market)
  • China
  • Japan (Largest Country Market)
  • South Korea
  • India (Fastest-Growing Country Market)
  • Australia
  • Rest of APAC
• Latin America (LATAM)
  • Brazil (Largest and Fastest-Growing Country Market)
  • Mexico
  • Rest of LATAM
• Middle East and Africa (MEA)
  • Saudi Arabia (Largest Country Market)
  • South Africa
  • U.A.E. (Fastest-Growing Country Market)
  • Rest of MEA

Biosensors Market Competitive Landscape

• The market is severely fragmented due to the wide variety of technologies that biosensors are based on.
• Additionally, these instruments are used in an extensive array of industries, from healthcare and environmental monitoring to food & beverage processing and forensics.
• This opens up opportunities for many companies, most of whom cater to a few specific applications.
• Another factor that fragments the market is the availability of standalone sensors, sensor patches, and end-use devices embedded with sensors, such as blood glucose monitors, air quality sensors, breathalyzers, and smartwatches.

Biosensors Market News

• In January 2025, Infineon Technologies AG combined its RF and sensor businesses into a new single business unit.
• In December 2024, NXP Semiconductors NV and Vanguard International Semiconductor Corporation JV VisionPower Semiconductor Manufacturing Company began the construction of its 300-mm wafer fabrication factory in Tampines, Singapore. Slated to begin production in 2027, the factory will produce almost 55,000 wafers every month from 2029 onward.
• In July 2024, Analog Devices Inc. announced that it will integrate its expertise in digital and analogue semiconductors with applied biology experience of Flagship Pioneering to enable enhanced measurements, biological insights, precision diagnostics, and more-effective interventions.
• In April 2024, STMicroelectronics NV expanded its line of edge AI sensor with the launch of LSM6DSV32X 6-axis inertial module. With its 4,000-degree-per-second gyroscope and 32-g accelerometer, the module enhances the measurement of intensive movements and impacts and enables longer runtimes in consumer wearables, impact and fall sensors, and asset trackers.